Literature DB >> 10711916

Dextromethorphan challenge in alcohol-dependent patients and controls.

C G Schütz, M Soyka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711916     DOI: 10.1001/archpsyc.57.3.291

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  5 in total

1.  Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremens.

Authors:  Andre Tadic; Norbert Dahmen; Armin Szegedi; Dan Rujescu; Ina Giegling; Gabriele Koller; Ion Anghelescu; Christoph Fehr; Christoph Klawe; Ullrich W Preuss; Thomas Sander; Mohammad R Toliat; Peter Singer; Brigitta Bondy; Michael Soyka
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-19       Impact factor: 5.270

2.  Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence.

Authors:  John H Krystal; Ismene L Petrakis; Diana Limoncelli; Susan Krasnicki Nappi; Louis Trevisan; Brian Pittman; Deepak C D'Souza; Raymond F Suckow
Journal:  Neuropsychopharmacology       Date:  2010-12-01       Impact factor: 7.853

3.  High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.

Authors:  Chad J Reissig; Lawrence P Carter; Matthew W Johnson; Miriam Z Mintzer; Margaret A Klinedinst; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2012-04-13       Impact factor: 4.530

4.  Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans.

Authors:  Lawrence P Carter; Chad J Reissig; Matthew W Johnson; Margaret A Klinedinst; Roland R Griffiths; Miriam Z Mintzer
Journal:  Drug Alcohol Depend       Date:  2012-09-16       Impact factor: 4.492

5.  Ethanol-like effects of thiopental and ketamine in healthy humans.

Authors:  D Dickerson; B Pittman; E Ralevski; A Perrino; D Limoncelli; J Edgecombe; G Acampora; J H Krystal; I Petrakis
Journal:  J Psychopharmacol       Date:  2008-11-21       Impact factor: 4.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.